These include the use of fibroblast cell lines from PD patients to understand the function of a key PD-associated protein, PINK1 [45], and the use of PBMCs to detect altered gene expression of proteins to use as biomarkers of Alzheimer’s disease [46,47]. This evidence concerns the gene PINK1 and Parkinson disease.